Cargando…
The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy
OBJECTIVE: To determine the relationship between a priori risk for fetal trisomy and the fraction of fetal cell-free DNA (cfDNA) in maternal blood. METHODS: A comparative analysis on fetal cfDNA amounts was performed in subjects stratified into a priori risk groups based on maternal age, prenatal sc...
Autores principales: | Brar, Herb, Wang, Eric, Struble, Craig, Musci, Thomas J., Norton, Mary E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545542/ https://www.ncbi.nlm.nih.gov/pubmed/22913322 http://dx.doi.org/10.3109/14767058.2012.722731 |
Ejemplares similares
-
Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy
por: Sparks, Andrew B, et al.
Publicado: (2012) -
Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing
por: Chen, Eric Z., et al.
Publicado: (2011) -
Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma
por: Ahmadi, Mohammad Hossein, et al.
Publicado: (2022) -
Non-invasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood
por: Lim, Ji Hyae, et al.
Publicado: (2013) -
Non-Invasive Epigenetic Detection of Fetal Trisomy 21 in First Trimester Maternal Plasma
por: Lim, Ji Hyae, et al.
Publicado: (2011)